Molecular Cloning
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Regulation of ATP Levels in Escherichia Coli Using CRISPR
Tao et al. Microb Cell Fact (2018) 17:147 https://doi.org/10.1186/s12934-018-0995-7 Microbial Cell Factories RESEARCH Open Access Regulation of ATP levels in Escherichia coli using CRISPR interference for enhanced pinocembrin production Sha Tao, Ying Qian, Xin Wang, Weijia Cao, Weichao Ma, Kequan Chen* and Pingkai Ouyang Abstract Background: Microbial biosynthesis of natural products holds promise for preclinical studies and treating diseases. For instance, pinocembrin is a natural favonoid with important pharmacologic characteristics and is widely used in preclinical studies. However, high yield of natural products production is often limited by the intracellular cofactor level, including adenosine triphosphate (ATP). To address this challenge, tailored modifcation of ATP concentration in Escherichia coli was applied in efcient pinocembrin production. Results: In the present study, a clustered regularly interspaced short palindromic repeats (CRISPR) interference sys- tem was performed for screening several ATP-related candidate genes, where metK and proB showed its potential to improve ATP level and increased pinocembrin production. Subsequently, the repression efciency of metK and proB were optimized to achieve the appropriate levels of ATP and enhancing the pinocembrin production, which allowed the pinocembrin titer increased to 102.02 mg/L. Coupled with the malonyl-CoA engineering and optimization of culture and induction condition, a fnal pinocembrin titer of 165.31 mg/L was achieved, which is 10.2-fold higher than control strains. Conclusions: Our results introduce a strategy to approach the efcient biosynthesis of pinocembrin via ATP level strengthen using CRISPR interference. Furthermore coupled with the malonyl-CoA engineering and induction condi- tion have been optimized for pinocembrin production. -
Molecular Cloning of DNA Fragments Produced by Restriction
Proc. Natl. Acad. Sci. USA Vol. 73, No. 5, pp. 1537-1541, May 1976 Biochemistry Molecular cloning of DNA fragments produced by restriction endonucleases SailI and BamI (DNA joining/plasmid/insertional inactivation of genes/Drosophila melanogaster) DEAN H. HAMER AND CHARLES A. THOMAS, JR. Department of Biological Chemistry, Harvard Medical School, Boston, Massachusetts 02115 Communicated by Bernard D. Dats, February 25,1976 ABSTRACT The highly specific restriction endonucleases cleaves various DNAs about once every 8 kb (kilobases), as SalI and BamI produce DNA fragments with complementary, compared to about once every 4 kb for EcoRI (16, 18). The cohesive termini that can be covalently joined by DNA ligase. resulting fragments have cohesive termini, and can be joined The Escherichia coli kanamycin resistance factor pML21 has to one another in head-to-tail, head-to-head, and one Sall site, at which DNA can be inserted without interfering probably with the expression of drug resistance or replication of the tail-to-tail orientation. Another highly specific restriction en- plasmid. A more convenient cloning vehicle can be made with donuclease that produces cohesive termini is BamI, from Ba- the tetracycline resistance factor pSC101, since insertion of cillus amyloliqefaciens H (G. Wilson and F. Young, personal DNA either at its single site for Sall or at that for BamI inacti- communication). We have shown that it cleaves D. melano- vates plasmid-specified drug resistance but not replication. To gaster DNA about once every 6 kb. This report describes the take advantage of this insertional inactivation, pSC101 was construction and verification of plasmid vehicles that allow one joined to a ColEl-ampicillin resistance plasmid having no Sall site, and to a ColEl-kanamycin resistance plasmid having no to clone and amplify potentially any DNA fragment produced BamI site. -
From Genes to Genomes
From Genes to Genomes Third Edition Concepts and Applications of DNA Technology Jeremy W. Dale, Malcolm von Schantz and Nick Plant University of Surrey, UK ©WILEY-BLACKWELL A John Wiley & Sons, Ltd., Publication Preface xiii 1 From Genes to Genomes 1 1.1 Introduction 1 1.2 Bask molecular biology 4 1.2.1 The DNA backbone 4 1.2.2 The base pairs 6 1.2.3 RNA structure 10 1.2.4 Nucleic acid synthesis 11 1.2.5 Coiling and supercoilin 11 1.3 What is a gene? 13 1.4 Information flow: gene expression 15 1.4.1 Transcription 16 1.4.2 Translation 19 1.5 Gene structure and organisation 20 1.5.1 Operons 20 1.5.2 Exons and introns 21 1.6 Refinements of the model 22 2 How to Clone a Gene 25 2.1 What is cloning? 25 2.2 Overview of the procedures 26 2.3 Extraction and purification of nucleic acids 29 2.3.1 Breaking up cells and tissues 29 2.3.2 Alkaline denaturation 31 2.3.3 Column purification 31 2.4 Detection and quantitation of nucleic acids 32 2.5 Gel electrophoresis 33 2.5.1 Analytical gel electrophoresis 33 2.5.2 Preparative gel electrophoresis 36 vi CONTENTS 2.6 Restriction endonudeases 36 2.6.1 Specificity 37 2.6.2 Sticky and blunt ends 40 2.7 Ligation 42 2.7.1 Optimising Ligation conditions 44 2.7.2 Preventing unwanted Ligation: alkaline phosphatase and double digests 46 2.7.3 Other ways of joining DNA fragments 48 2.8 Modification of restriction fragment ends 49 2.8.1 Linkers and adaptors 50 2.8.2 Homopolymer tailing 52 2.9 Plasmid vectors 53 2.9.1 Plasmid replication 54 2.9.2 Cloning sites 55 2.9.3 Selectable markers 57 2.9.4 Insertional inactivation -
Gibson Assembly Cloning Guide, Second Edition
Gibson Assembly® CLONING GUIDE 2ND EDITION RESTRICTION DIGESTFREE, SEAMLESS CLONING Applications, tools, and protocols for the Gibson Assembly® method: • Single Insert • Multiple Inserts • Site-Directed Mutagenesis #DNAMYWAY sgidna.com/gibson-assembly Foreword Contents Foreword The Gibson Assembly method has been an integral part of our work at Synthetic Genomics, Inc. and the J. Craig Venter Institute (JCVI) for nearly a decade, enabling us to synthesize a complete bacterial genome in 2008, create the first synthetic cell in 2010, and generate a minimal bacterial genome in 2016. These studies form the framework for basic research in understanding the fundamental principles of cellular function and the precise function of essential genes. Additionally, synthetic cells can potentially be harnessed for commercial applications which could offer great benefits to society through the renewable and sustainable production of therapeutics, biofuels, and biobased textiles. In 2004, JCVI had embarked on a quest to synthesize genome-sized DNA and needed to develop the tools to make this possible. When I first learned that JCVI was attempting to create a synthetic cell, I truly understood the significance and reached out to Hamilton (Ham) Smith, who leads the Synthetic Biology Group at JCVI. I joined Ham’s team as a postdoctoral fellow and the development of Gibson Assembly began as I started investigating methods that would allow overlapping DNA fragments to be assembled toward the goal of generating genome- sized DNA. Over time, we had multiple methods in place for assembling DNA molecules by in vitro recombination, including the method that would later come to be known as Gibson Assembly. -
Supplementary Table S1. Table 1. List of Bacterial Strains Used in This Study Suppl
Supplementary Material Supplementary Tables: Supplementary Table S1. Table 1. List of bacterial strains used in this study Supplementary Table S2. List of plasmids used in this study Supplementary Table 3. List of primers used for mutagenesis of P. intermedia Supplementary Table 4. List of primers used for qRT-PCR analysis in P. intermedia Supplementary Table 5. List of the most highly upregulated genes in P. intermedia OxyR mutant Supplementary Table 6. List of the most highly downregulated genes in P. intermedia OxyR mutant Supplementary Table 7. List of the most highly upregulated genes in P. intermedia grown in iron-deplete conditions Supplementary Table 8. List of the most highly downregulated genes in P. intermedia grown in iron-deplete conditions Supplementary Figures: Supplementary Figure 1. Comparison of the genomic loci encoding OxyR in Prevotella species. Supplementary Figure 2. Distribution of SOD and glutathione peroxidase genes within the genus Prevotella. Supplementary Table S1. Bacterial strains Strain Description Source or reference P. intermedia V3147 Wild type OMA14 isolated from the (1) periodontal pocket of a Japanese patient with periodontitis V3203 OMA14 PIOMA14_I_0073(oxyR)::ermF This study E. coli XL-1 Blue Host strain for cloning Stratagene S17-1 RP-4-2-Tc::Mu aph::Tn7 recA, Smr (2) 1 Supplementary Table S2. Plasmids Plasmid Relevant property Source or reference pUC118 Takara pBSSK pNDR-Dual Clonetech pTCB Apr Tcr, E. coli-Bacteroides shuttle vector (3) plasmid pKD954 Contains the Porpyromonas gulae catalase (4) -
Thermodynamics of DNA Binding and Break Repair by the Pol I DNA
Louisiana State University LSU Digital Commons LSU Doctoral Dissertations Graduate School 2011 Thermodynamics of DNA binding and break repair by the Pol I DNA polymerases from Escherichia coli and Thermus aquaticus Yanling Yang Louisiana State University and Agricultural and Mechanical College, [email protected] Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations Recommended Citation Yang, Yanling, "Thermodynamics of DNA binding and break repair by the Pol I DNA polymerases from Escherichia coli and Thermus aquaticus" (2011). LSU Doctoral Dissertations. 3092. https://digitalcommons.lsu.edu/gradschool_dissertations/3092 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please [email protected]. THERMODYNAMICS OF DNA BINDING AND BREAK REPAIR BY THE POL I DNA POLYMERASES FROM ESCHERICHIA COLI AND THERMUS AQUATICUS A Dissertation Submitted to the Graduate Faculty of the Louisiana State University and Agricultural and Mechanical College in partial fulfillment of the requirements for the degree of Doctor of Philosophy in The Department of Biological Sciences by Yanling Yang B.S., Qufu Normal University, 2001 M.S., Institute of Microbiology, Chinese Academy Sciences, 2004 M.S. in statistics, Louisiana State University, 2009 December 2011 ACKNOWLEDGMENTS I would like to express my sincere gratitude to some of the people without whose support and guidance none of this work would have been possible. I deeply thank my advisor, Dr. Vince J. LiCata. His guidance and suggestions have been critical to the completion of this research work and the writing of this dissertation. -
Cloning of Gene Coding Glyceraldehyde-3-Phosphate Dehydrogenase Using Puc18 Vector
Available online a t www.pelagiaresearchlibrary.com Pelagia Research Library European Journal of Experimental Biology, 2015, 5(3):52-57 ISSN: 2248 –9215 CODEN (USA): EJEBAU Cloning of gene coding glyceraldehyde-3-phosphate dehydrogenase using puc18 vector Manoj Kumar Dooda, Akhilesh Kushwaha *, Aquib Hasan and Manish Kushwaha Institute of Transgene Life Sciences, Lucknow (U.P), India _____________________________________________________________________________________________ ABSTRACT The term recombinant DNA technology, DNA cloning, molecular cloning, or gene cloning all refers to the same process. Gene cloning is a set of experimental methods in molecular biology and useful in many areas of research and for biomedical applications. It is the production of exact copies (clones) of a particular gene or DNA sequence using genetic engineering techniques. cDNA is synthesized by using template RNA isolated from blood sample (human). GAPDH (Glyceraldehyde 3-phosphate dehydrogenase) is one of the most commonly used housekeeping genes used in comparisons of gene expression data. Amplify the gene (GAPDH) using primer forward and reverse with the sequence of 5’-TGATGACATCAAGAAGGTGGTGAA-3’ and 5’-TCCTTGGAGGCCATGTGGGCCAT- 3’.pUC18 high copy cloning vector for replication in E. coli, suitable for “blue-white screening” technique and cleaved with the help of SmaI restriction enzyme. Modern cloning vectors include selectable markers (most frequently antibiotic resistant marker) that allow only cells in which the vector but necessarily the insert has been transfected to grow. Additionally the cloning vectors may contain color selection markers which provide blue/white screening (i.e. alpha complementation) on X- Gal and IPTG containing medium. Keywords: RNA isolation; TRIzol method; Gene cloning; Blue/white screening; Agarose gel electrophoresis. -
How to Clone Ref V1-2
A primer on cloning in E. coli Michael Nonet Department of Neuroscience Washington University Medical School St Louis, MO 63110 Draft 1.2.1 Nov. 10, 2019 Things to add: gel electrophoresis methods basic bacteriology methods Index Overview E. coli vectors! 6 Types of E. coli vectors! 6 Components of typical plasmid vectors! 6 Origin of replication! 6 Antibiotic resistance genes! 7 Master Cloning Sites! 7 LacZ"! 7 ccdB ! 8 Design of DNA constructs! 9 Choice of vector! 9 Source of insert! 9 Plasmids! 9 Genomic or cDNA! 9 Synthetic DNA! 10 Overview of different approaches to creating clones! 10 Restriction enzyme based cloning! 10 Single vs. double cut method! 11 Blunt vs “sticky” restriction sites! 11 Typical methodology for restriction enzyme cloning! 11 Golden Gate style cloning! 12 Typical methodology for Golden Gate cloning! 12 Gateway cloning! 13 Typical methodology for Gateway cloning! 14 Gibson assembly cloning! 15 Typical procedure for Gibson assembly! 15 Site directed mutagenesis! 16 PCR overlap approach! 16 DpnI mediated site directed mutagenesis! 16 Typical procedure for site directed mutagenesis! 17 Detailed methodology for all five methods Restriction enzyme cloning! 18 Designing the cloning strategy ! 18 Determining which vector to use! 18 Designing the insert fragment! 19 Designing primers! 19 Vector preparation! 19 Insert preparation! 19 Detailed protocol! 20 Step 1: Design oligonucleotides to amplify the product of interest! 20 Step 2: PCR amplification of insert DNA! 20 Step 3: Clean-up purification of PCR product! 21 Step 4: Digestion of products! 21 Step 5: Gel purification of products! 22 Step 6: Ligation! 22 Step 7: Transformation of E. -
The Cloning Guide the First Step Towards a Succesful Igem Project Igem Bonn NRP-UEA Igem
The Cloning Guide The first step towards a succesful iGEM Project iGEM Bonn NRP-UEA iGEM iGEM Manchester-Graz iGEM Evry iGEM Vanderbilt iGEM Minnesota Carnegie Mellon iGEM iGEM Sydney UIUC iGEM iGEM York iGEM Toulouse iGEM Pasteur UCLA iGEM iGEM Stockholm Preface The cloning guide which is lying before you or on your desktop is a document brought to you by iGEM TU Eindhoven in collaboration with numerous iGEM (International Genetically Engi- neered Machine) teams during iGEM 2015. An important part in the iGEM competition is the collabration of your own team with other teams. These collaborations are fully in line with the dedications of the iGEM Foundation on education and competition, the advancement of syn- thetic biology, and the development of an open community and collaboration. Collaborations between groups of (undergrad and overgrad) students can lead to nice products, as we have tried to provide one for you in 2015. In order to compile a cloning guide, several iGEM teams from all over the world have been con- tacted to cooperate on this. Finally fifiteen teams contributed in a fantastic way and a cloning guide consisting of the basics about nine different cloning methods and experiences of teams working with them has been realized. Without the help of all collaborating teams this guide could never have been realized, so we will thank all teams in advance. This guide may be of great help when new iGEM teams (edition 2016 and later) are at the point of designing their project. How to assemble the construct for you project, is an important choice which is possibly somewhat easier to make after reading this guide. -
Psp73 Vector Technical Bulletin #TB041
tb041.0906.qxp 9/25/2006 10:44 AM Page a Technical Bulletin pSP73 Vector INSTRUCTIONS FOR USE OF PRODUCT P2221. PRINTED IN USA. Revised 9/06 Part# TB041 AF9TB041 0906TB041 tb041.0906.qxp 9/25/2006 10:46 AM Page 1 pSP73 Vector All technical literature is available on the Internet at: www.promega.com/tbs/ Please visit the web site to verify that you are using the most current version of this Technical Bulletin. Please contact Promega Technical Services if you have questions on use of this system. E-mail: [email protected] I. Description..........................................................................................................1 II. Product Components and Storage Conditions ............................................1 III. pSP73 Vector Multiple Cloning Region and Circle Map..........................2 IV. pSP73 Vector Restriction Sites........................................................................4 V. Related Products ................................................................................................6 VI. Reference .............................................................................................................7 I. Description The pSP73 Vector (1) offers a wide range of restriction sites, providing greater versatility in cloning and transcription of RNA in vitro. The pSP73 Vector contains the SP6 and T7 RNA polymerase promoters and a unique multiple cloning region, which includes restriction sites for BglII, EcoRV, ClaI, EcoRI, SacI, KpnI, SmaI, BamHI, XbaI, AccI, SalI, PstI, SphI, HindIII, PvuII and XhoI. The sequences of Promega vectors are available online at www.promega.com/vectors/ and are also available from the GenBank® database. II. Product Components and Storage Conditions Product Size Cat.# pSP73 Vector 20µg P2221 Storage Conditions: Store the pSP73 Vector at –20°C. Promega Corporation · 2800 Woods Hollow Road · Madison, WI 53711-5399 USA Toll Free in USA 800-356-9526 · Phone 608-274-4330 · Fax 608-277-2516 · www.promega.com Printed in USA. -
An Interplay Between Nonsense-Mediated Decay and DNA Damage Response Pathways
An interplay between nonsense-mediated decay and DNA damage response pathways Fatemeh Ghasemi Master Thesis Department of Biosciences Faculty of Mathematics and Natural Sciences UNIVERSITY OF OSLO June 2020 © Fatemeh Ghasemi June 2020 An interplay between nonsense-mediated decay and DNA damage response pathways Supervisor: Rafal Ciosk Co-supervisors: Pooja Kumari, Yanwu Guo http://www.duo.uio.no/ Trykk: Reprosentralen, Universitetet i Oslo II Acknowledgement The work presented in this master thesis was carried out at the Department of Biosciences, University of Oslo in the period between April 2019 to June 2020. First and foremost, I’d like to thank my supervisor Rafal Ciosk for giving me the opportunity to work in his group. Thank you for all your help and positivity. I greatly appreciate everything I learned in my time here. Second, I’d like to express my deep gratitude to my co-supervisor Pooja Kumari, without whom I couldn’t have done this. Thank you for your daily guidance and support in the lab, I truly appreciate all the advice you’ve given me. Further, I’d like to thank everyone else in the Ciosk group, especially Yanwu Guo, for all their practical help in the lab, and for writing this thesis. Your input and advice have been greatly appreciated. Divya and Melanie, thank you for cheering me up every single day. Thank you also to all my friends in the Falnes group who helped me out when I was wandering the hallway looking lost. Lastly, I would like to thank my parents for their unending love and support, and for believing in me. -
Recombinant DNA Technology and Its Applications: a Review S
International Journal of MediPharm Research ISSN:2395-423X www.medipharmsai.com Vol.04, No.02, pp 79-88, 2018 Recombinant DNA Technology and its Applications: A Review S. A. Shinde*, S. A. Chavhan, S. B.Sapkal, V. N. Shrikhande Dr. Rajendra Gode College of Pharmacy, Malkapur Dist- Buldana(MS), India Mob. No:-09890251512 Abstract: Biotechnology which is synonymous with genetic engineering or recombinant DNA (rDNA) is an industrial process that uses the scientific research on DNA for practical applications. rDNA is a form of artificial DNA that is made through the combination or insertion of one or more DNA strands,It offered new opportunities for innovations to produce a wide range of therapeutic products with immediate effect in the medical genetics and biomedicine by modifying microorganisms, animals, and plants to yield medically useful substances.Recombinant DNA technology is playing a vital role in improving health conditions by developing new vaccines and pharmaceuticals. This review gives brief introduction to rDNA and its applications in various fields. Key words: Chimeric DNA, restriction enzymes, Transgenic Plants, Gene Therapy. Introduction: Human life is greatly affected by three factors: deficiency of food, health problems, and environmental issues. Food and health are basic human requirements beside a clean and safe environment. With increasing world's population at a greater rate, human requirements for food are rapidly increasing. Humans require safe- food at reasonable price. Several human related health issues across the globe cause large number of deaths. Approximately 36 million people die each year from noncommunicable and communicable diseases, such as cardiovascular diseases, cancer, diabetes, AIDS/HIV, tuberculosis, malaria.